Relapse Rate and MRI Activity in Young Adult Patients With Multiple Sclerosis: A Post Hoc Analysis of Phase 3 Fingolimod Trials.

Gärtner, Jutta; Chitnis, Tanuja; Ghezzi, Angelo; Pohl, Daniela; Brück, Wolfgang; Häring, Dieter Adrian; Karlsson, Goeril; Putzki, Norman

Gärtner, Jutta; Chitnis, Tanuja; Ghezzi, Angelo; Pohl, Daniela; Brück, Wolfgang; Häring, Dieter Adrian; Karlsson, Goeril; Putzki, Norman.

Afiliação

Gärtner J; Department of Pediatrics and Adolescent Medicine, German Centre for Multiple Sclerosis in Childhood and Adolescence, University Medical Center Göttingen, Germany.
Chitnis T; Partners Pediatric Multiple Sclerosis Center, Massachusetts General Hospital, USA.
Ghezzi A; Centro Studi Sclerosi Multipla, Italy.
Pohl D; Division of Neurology, Children's Hospital of Eastern Ontario, University of Ottawa, Canada.
Brück W; Institute of Neuropathology, University Medical Center Göttingen, Germany.
Häring DA; Novartis Pharma AG, Switzerland.
Karlsson G; Novartis Pharma AG, Switzerland.
Putzki N; Novartis Pharma AG, Switzerland.

Mult Scler J Exp Transl Clin ; 4(2): 2055217318778610, 2018.

Article em En | MEDLINE | ID: mdl-29854416

Palavras-chave

Age; disability; fingolimod; multiple sclerosis; relapse rates; young adult

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Mult Scler J Exp Transl Clin Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google